GENE ONLINE|News &
Opinion
Blog

Cell and Gene Therapy
BIO Asia 2021 Highlights: Realizing The Promise of Cell and Gene Therapies
2021-08-02
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
Celgene Spinoff Arrives Wall Street with a $138 Million SPAC Deal
2021-07-19
In Quest For Scalability in Cell Therapy Manufacturing, Cellares Partners with Poseida
2021-07-14
R&D
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
Gilead’s Yescarta Becomes First CAR-T Therapy to Score Regulatory Approval in China
2021-06-27
China’s Legend Biotech to Build a CAR-T Therapy Production Site in Belgium
2021-06-24
Blackstone Pumps $250 Million in CAR-T Startup, Betting on Intellia’s and Cellex’s Technologies
2021-06-23
ASCO21: Current Issues with CAR T Cells for Hematologic Malignancies
2021-06-08
ASGCT21 Highlights: Present Trends and Future Directions of Gene and Cell Therapies in Immuno-Oncology
2021-05-14
Charles River Labs Expands Manufacturing Capabilities Through CDMO Acquisition
2021-02-23
BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
2021-02-18
R&D
AbbVie Signs Off-the-Shelf CAR-T Therapy Pact with Jennifer Doudna’s Caribou Biosciences
2021-02-11
CRISPR/Cas9 Gene Editing in Cell and Gene Therapies
2020-11-08
Takeda Established Capabilities to Engine Cell Therapy Manufacturing
2020-09-18
1 2 3 4 5
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top